Search - tctmd.com

Displaying 41 - 55 of 55

Sort: Relevancy | Date

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

L.A. McKeown

December 10, 2015

News Daily News

Does the Watchman LAA Occluder Reduce Bleeding?

L.A. McKeown

November 25, 2015

News Conference News AHA 2015

Is Watchman Cost-effective? That Depends Where You Look

Todd Neale

November 07, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Daily News

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Yael L. Maxwell

July 17, 2015

News Daily News

Statement on LAA Closure Highlights Key Issues for Growing Field

July 02, 2015

News Industry News

Patients Undergoing Catheter Ablation Presented at Heart Rhythm 2015

May 15, 2015

News Daily News

Study Documents Complications of LAA Closure With the Lariat Device

May 05, 2015

News Daily News

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

Todd Neale

February 17, 2015

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Caitlin E. Cox

January 28, 2015

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Caitlin E. Cox

January 20, 2011

Advertisement

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

Does the Watchman LAA Occluder Reduce Bleeding?

Is Watchman Cost-effective? That Depends Where You Look

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Statement on LAA Closure Highlights Key Issues for Growing Field

Patients Undergoing Catheter Ablation Presented at Heart Rhythm 2015

Study Documents Complications of LAA Closure With the Lariat Device

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Watchman Works Just as Well Without Warfarin-Protected Transition

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content